Aska PharmaceuticalLtd. (4886.TSE) Q1 2026 Earnings

2FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
35
43
51
59

Details

Expected EPS
N/A
Actual EPS
59
Surprise EPS
59
Surprise Percent
+∞%

Description

Aska PharmaceuticalLtd. (4886.TSE) has reported earnings of 59 per share for Q1 2026.

0 Comments

Share your thoughts